Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Northshore University Hospital, Manhasset, New York UT Southwestern Medical Center, Dallas, Texas The Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas